Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1992 Oct;5(4):420–432. doi: 10.1128/cmr.5.4.420

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance.

L R Peterson 1, C J Shanholtzer 1
PMCID: PMC358258  PMID: 1423219

Abstract

Bactericidal testing has been used for several decades as a guide for antimicrobial therapy of serious infections. Such testing is most frequently performed when bactericidal antimicrobial agent therapy is considered necessary (such as when treating infectious endocarditis or infection in an immunocompromised host). It has also been used to ensure that the infecting organism is killed by (not tolerant to) usually bactericidal compounds. However, few data are available to support the role of such tests in direct patient care. Several important variables affect the reproducibility of the test results; however, proposed reference methods are now available for performing the MBC test. With minor modifications, these can provide a standardized approach for laboratories that need to perform them. Currently, little evidence is available to support the routine use of such testing for the care of individual patients. However, testing of new (investigational) antimicrobial agents can be beneficial in determining their potential to provide bactericidal antimicrobial activity during clinical use. New methods to assess bactericidal activity are being developed, but as yet none have been rigorously tested in patient care settings; further, for most of these methods, little information is available as to which technical parameters affect their results. In clinical laboratories, all bactericidal tests must be performed with rigorously standardized techniques and adequate controls, bearing in mind the limitations of the currently available test procedures.

Full text

PDF
420

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ampel N. M., Keating M. H., Moon-McDermott L., Peter G., Zinner S. H. Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureus. J Antimicrob Chemother. 1984 May;13(5):417–421. doi: 10.1093/jac/13.5.417. [DOI] [PubMed] [Google Scholar]
  2. Atkinson B. A., Amaral L. Sublethal concentrations of antibiotics, effects on bacteria and the immune system. Crit Rev Microbiol. 1982;9(2):101–138. doi: 10.3109/10408418209104487. [DOI] [PubMed] [Google Scholar]
  3. Auckenthaler R., Wilson W. R., Wright A. J., Washington J. A., 2nd, Durack D. T., Geraci J. E. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrob Agents Chemother. 1982 Sep;22(3):448–452. doi: 10.1128/aac.22.3.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bamberger D. M., Peterson L. R., Gerding D. N., Moody J. A., Fasching C. E. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model. J Antimicrob Chemother. 1986 Jul;18(1):51–63. doi: 10.1093/jac/18.1.51. [DOI] [PubMed] [Google Scholar]
  5. Baquero F. From accuracy towards truth: the BSAC Working Party's guide to sensitivity testing. J Antimicrob Chemother. 1991 Jun;27(6):701–702. doi: 10.1093/jac/27.6.701. [DOI] [PubMed] [Google Scholar]
  6. Barry A. L., Badal R. E., Hawkinson R. W. Influence of inoculum growth phase on microdilution susceptibility tests. J Clin Microbiol. 1983 Sep;18(3):645–651. doi: 10.1128/jcm.18.3.645-651.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Barry A. L., Lasner R. A. In-vitro methods for determining minimal lethal concentrations of antimicrobial agents. Am J Clin Pathol. 1979 Jan;71(1):88–92. doi: 10.1093/ajcp/71.1.88. [DOI] [PubMed] [Google Scholar]
  8. Bayer A. S., Morrison J. O. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Aug;26(2):220–223. doi: 10.1128/aac.26.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brennan R. O., Durack D. T. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother. 1983 Feb;23(2):273–277. doi: 10.1128/aac.23.2.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Briceland L. L., Pasko M. T., Mylotte J. M. Serum bactericidal rate as measure of antibiotic interactions. Antimicrob Agents Chemother. 1987 May;31(5):679–685. doi: 10.1128/aac.31.5.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brown M. R., Costerton J. W., Gilbert P. Extrapolating to bacterial life outside the test tube. J Antimicrob Chemother. 1991 May;27(5):565–567. doi: 10.1093/jac/27.5.565. [DOI] [PubMed] [Google Scholar]
  12. Brown M. R., Williams P. Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):7–14. doi: 10.1093/jac/15.suppl_a.7. [DOI] [PubMed] [Google Scholar]
  13. Casewell M. W., Hill R. L. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent. J Antimicrob Chemother. 1987 Jan;19(1):1–5. doi: 10.1093/jac/19.1.1. [DOI] [PubMed] [Google Scholar]
  14. Chuard C., Lucet J. C., Rohner P., Herrmann M., Auckenthaler R., Waldvogel F. A., Lew D. P. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis. 1991 Jun;163(6):1369–1373. [PubMed] [Google Scholar]
  15. Coleman D. L., Horwitz R. I., Andriole V. T. Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. Am J Med. 1982 Aug;73(2):260–267. doi: 10.1016/0002-9343(82)90188-7. [DOI] [PubMed] [Google Scholar]
  16. Dankert J., Holloway Y., Joldersma W., Hess J. Screening for penicillin tolerance in viridans streptococci by a simple disk method. J Clin Microbiol. 1982 Oct;16(4):744–746. doi: 10.1128/jcm.16.4.744-746.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. DeGirolami P. C., Eliopoulos G. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring. Clin Lab Med. 1987 Sep;7(3):499–512. [PubMed] [Google Scholar]
  18. Denny A. E., Peterson L. R., Gerding D. N., Hall W. H. Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Arch Intern Med. 1979 Sep;139(9):1026–1031. [PubMed] [Google Scholar]
  19. Drake T. A., Hackbarth C. J., Sande M. A. Value of serum tests in combined drug therapy of endocarditis. Antimicrob Agents Chemother. 1983 Nov;24(5):653–657. doi: 10.1128/aac.24.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Drusano G., Standiford H., Ryan P., McNamee W., Tatem B., Schimpff S. Correlation of predicted serum bactericidal activities and values measured in volunteers. Eur J Clin Microbiol. 1986 Feb;5(1):88–92. doi: 10.1007/BF02013475. [DOI] [PubMed] [Google Scholar]
  21. Dutcher B. S., Reynard A. M., Beck M. E., Cunningham R. K. Potentiation of antibiotic bactericidal activity by normal human serum. Antimicrob Agents Chemother. 1978 May;13(5):820–826. doi: 10.1128/aac.13.5.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Eliopoulos G. M., Moellering R. C., Jr Principles of antibiotic therapy. Med Clin North Am. 1982 Jan;66(1):3–15. doi: 10.1016/s0025-7125(16)31437-7. [DOI] [PubMed] [Google Scholar]
  23. Eng R. H., Smith S. M., Cherubin C. E., Tan E. N. Evaluation of two methods for overcoming the antibiotic carry-over effect. Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):34–38. doi: 10.1007/BF01967095. [DOI] [PubMed] [Google Scholar]
  24. Fantin B., Carbon C. In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother. 1992 May;36(5):907–912. doi: 10.1128/aac.36.5.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fantin B., Leggett J., Ebert S., Craig W. A. Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model. Antimicrob Agents Chemother. 1991 Jul;35(7):1413–1422. doi: 10.1128/aac.35.7.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Fasching C. E., Gerding D. N., Peterson L. R. Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli. Am J Med. 1987 Apr 27;82(4A):80–86. [PubMed] [Google Scholar]
  27. Fasching C. E., Peterson L. R., Moody J. A., Sinn L. M., Gerding D. N. Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy. J Lab Clin Med. 1990 Nov;116(5):697–706. [PubMed] [Google Scholar]
  28. Fass R. J. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits. J Infect Dis. 1984 Jun;149(6):904–912. doi: 10.1093/infdis/149.6.904. [DOI] [PubMed] [Google Scholar]
  29. Fernandes C. J., Stevens D. A., Groot obbink D. J., Ackerman V. P. A replicator method for the combined determination of minimum inhibitory concentration and minimum bactericidal concentration. J Antimicrob Chemother. 1985 Jan;15(1):53–60. doi: 10.1093/jac/15.1.53. [DOI] [PubMed] [Google Scholar]
  30. GOULD J. C. The laboratory control of antibiotic therapy. Br Med Bull. 1960 Jan;16:29–34. doi: 10.1093/oxfordjournals.bmb.a069787. [DOI] [PubMed] [Google Scholar]
  31. Gerding D. N., Peterson L. R., Moody J. A., Fasching C. E. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):207–219. doi: 10.1093/jac/15.suppl_a.207. [DOI] [PubMed] [Google Scholar]
  32. Gilbert D. N., Eubanks N. Effect of pH and human serum on the susceptibility of group D streptococci (Enterococci) to ampicillin in vitro. Antimicrob Agents Chemother. 1975 Apr;7(4):387–395. doi: 10.1128/aac.7.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Goessens W. H., Fontijne P., Michel M. F. Factors influencing detection of tolerance in Staphylococcus aureus. Antimicrob Agents Chemother. 1982 Sep;22(3):364–368. doi: 10.1128/aac.22.3.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Goldman P. L., Petersdorf R. G. Significance of methicillin tolerance in experimental staphylococcal endocarditis. Antimicrob Agents Chemother. 1979 Jun;15(6):802–806. doi: 10.1128/aac.15.6.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Greenwood D. In vitro veritas? Antimicrobial susceptibility tests and their clinical relevance. J Infect Dis. 1981 Oct;144(4):380–385. doi: 10.1093/infdis/144.4.380. [DOI] [PubMed] [Google Scholar]
  36. Greenwood D., O'Grady F. Trimodal response of Escherichia coli and Proteus mirabilis to penicillins. Nature. 1970 Oct 31;228(5270):457–458. doi: 10.1038/228457a0. [DOI] [PubMed] [Google Scholar]
  37. Greenwood D. Phenotypic variability and sensitivity tests: carry on regardless. J Antimicrob Chemother. 1991 Jun;27(6):861–862. doi: 10.1093/jac/27.6.861. [DOI] [PubMed] [Google Scholar]
  38. Gresser-Burns M. E., Shanholtzer C. J., Peterson L. R., Gerding D. N. Occurrence and reproducibility of the "skip" phenomenon in bactericidal testing of Staphylococcus aureus. Diagn Microbiol Infect Dis. 1987 Apr;6(4):335–342. doi: 10.1016/0732-8893(87)90184-2. [DOI] [PubMed] [Google Scholar]
  39. Hallander H. O., Dornbusch K., Gezelius L., Jacobson K., Karlsson I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother. 1982 Nov;22(5):743–752. doi: 10.1128/aac.22.5.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Handwerger S., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis. 1985 May-Jun;7(3):368–386. doi: 10.1093/clinids/7.3.368. [DOI] [PubMed] [Google Scholar]
  41. Hilf M., Yu V. L., Sharp J., Zuravleff J. J., Korvick J. A., Muder R. R. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989 Nov;87(5):540–546. doi: 10.1016/s0002-9343(89)80611-4. [DOI] [PubMed] [Google Scholar]
  42. Holm S. E., Tornqvist I. O., Cars O. Paradoxical effects of antibiotics. Scand J Infect Dis Suppl. 1990;74:113–117. [PubMed] [Google Scholar]
  43. Isenberg H. D. Antimicrobial susceptibility testing: a critical evaluation. J Antimicrob Chemother. 1988 Jul;22 (Suppl A):73–86. doi: 10.1093/jac/22.supplement_a.73. [DOI] [PubMed] [Google Scholar]
  44. Ishida K., Guze P. A., Kalmanson G. M., Albrandt K., Guze L. B. Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob Agents Chemother. 1982 Apr;21(4):688–690. doi: 10.1128/aac.21.4.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Jacobs M. R., Myers C. Diagnostic microbiology and therapeutic drug monitoring in pediatric infectious diseases. Pediatr Clin North Am. 1983 Feb;30(1):135–159. doi: 10.1016/s0031-3955(16)34326-7. [DOI] [PubMed] [Google Scholar]
  46. James P. A. Comparison of four methods for the determination of MIC and MBC of penicillin for viridans streptococci and the implications for penicillin tolerance. J Antimicrob Chemother. 1990 Feb;25(2):209–216. doi: 10.1093/jac/25.2.209. [DOI] [PubMed] [Google Scholar]
  47. Jones R. N. Antimicrobial susceptibility testing (AST): a review of changing trends, quality control guidelines, test accuracy, and recommendation for the testing of beta-lactam drugs. Diagn Microbiol Infect Dis. 1983 Mar;1(1):1–24. doi: 10.1016/0732-8893(83)90028-7. [DOI] [PubMed] [Google Scholar]
  48. Jones R. N., Edson D. C. Antibiotic susceptibility testing accuracy. Review of the College of American Pathologists Microbiology Survey, 1972-1983. Arch Pathol Lab Med. 1985 Jul;109(7):595–601. [PubMed] [Google Scholar]
  49. Jordan G. W., Kawachi M. M. Analysis of serum bactericidal activity in endocarditis, osteomyelitis, and other bacterial infections. Medicine (Baltimore) 1981 Jan;60(1):49–61. doi: 10.1097/00005792-198101000-00005. [DOI] [PubMed] [Google Scholar]
  50. Kaye D. The clinical significance of tolerance of Staphylococcus aureus. Ann Intern Med. 1980 Dec;93(6):924–926. doi: 10.7326/0003-4819-93-6-924. [DOI] [PubMed] [Google Scholar]
  51. Kiehn T. E., Ellner P. D., Budzko D. Role of the microbiology laboratory in care of the immunosuppressed patient. Rev Infect Dis. 1989 Nov-Dec;11 (Suppl 7):S1706–S1710. doi: 10.1093/clinids/11.supplement_7.s1706. [DOI] [PubMed] [Google Scholar]
  52. Kim K. S., Anthony B. F. Importance of bacterial growth phase in determining minimal bactericidal concentrations of penicillin and methicillin. Antimicrob Agents Chemother. 1981 Jun;19(6):1075–1077. doi: 10.1128/aac.19.6.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Kim K. S., Anthony B. F. Use of penicillin-gradient and replicate plates for the demonstration of tolerance to penicillin in streptococci. J Infect Dis. 1983 Sep;148(3):488–491. doi: 10.1093/infdis/148.3.488. [DOI] [PubMed] [Google Scholar]
  54. Kim K. S., Yoshimori R. N., Imagawa D. T., Anthony B. F. Importance of medium in demonstrating penicillin tolerance by group B streptococci. Antimicrob Agents Chemother. 1979 Aug;16(2):214–216. doi: 10.1128/aac.16.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Korvick J. A., Yu V. L. Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991 Nov;35(11):2167–2172. doi: 10.1128/aac.35.11.2167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Laverdiere M., Sabath L. D. Historical survey of tests to determine bacterial susceptibility to antimicrobial agents. Mt Sinai J Med. 1977 Jan-Feb;44(1):73–88. [PubMed] [Google Scholar]
  57. Levine D. P., Fromm B. S., Reddy B. R. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991 Nov 1;115(9):674–680. doi: 10.7326/0003-4819-115-9-674. [DOI] [PubMed] [Google Scholar]
  58. Lorian V., Burns L. Predictive value of susceptibility tests for the outcome of antibacterial therapy. J Antimicrob Chemother. 1990 Jan;25(1):175–181. doi: 10.1093/jac/25.1.175. [DOI] [PubMed] [Google Scholar]
  59. MacLowry J. D. Perspective: the serum dilution test. J Infect Dis. 1989 Oct;160(4):624–626. doi: 10.1093/infdis/160.4.624. [DOI] [PubMed] [Google Scholar]
  60. Mackowiak P. A., Marling-Cason M., Cohen R. L. Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis. 1982 Apr;145(4):550–553. doi: 10.1093/infdis/145.4.550. [DOI] [PubMed] [Google Scholar]
  61. Marcoux J. A., Washington J. A., 2nd Pitfalls in identification of methicillin-resistant Staphylococcus aureus. Appl Microbiol. 1969 Oct;18(4):699–700. doi: 10.1128/am.18.4.699-700.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Masuda G., Tomioka S. Quantitative assessment of bactericidal activities of beta-lactam antibiotics by agar plate method. Antimicrob Agents Chemother. 1978 Oct;14(4):587–595. doi: 10.1128/aac.14.4.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Masuda G., Tomioka S., Uchida H., Hasegawa M. Bacteriostatic and bactericidal activities of selected beta-lactam antibiotics studied on agar plates. Antimicrob Agents Chemother. 1977 Mar;11(3):376–382. doi: 10.1128/aac.11.3.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Mayhall C. G., Apollo E. Effect of storage and changes in bacterial growth phase and antibiotic concentrations on antimicrobial tolerance in Staphylococcus aureus. Antimicrob Agents Chemother. 1980 Nov;18(5):784–788. doi: 10.1128/aac.18.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Mellors J. W., Coleman D. L., Andriole V. T. Value of the serum bactericidal test in management of patients with bacterial endocarditis. Eur J Clin Microbiol. 1986 Feb;5(1):67–70. doi: 10.1007/BF02013472. [DOI] [PubMed] [Google Scholar]
  66. Moody J. A., Fasching C. E., Peterson L. R., Gerding D. N. Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae. Diagn Microbiol Infect Dis. 1987 Jan;6(1):59–67. doi: 10.1016/0732-8893(87)90115-5. [DOI] [PubMed] [Google Scholar]
  67. Mulligan M. J., Cobbs C. G. Bacteriostatic versus bactericidal activity. Infect Dis Clin North Am. 1989 Sep;3(3):389–398. [PubMed] [Google Scholar]
  68. Murray P. R., Jorgensen J. H. Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother. 1981 Jul;20(1):66–70. doi: 10.1128/aac.20.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Norden C. W., Keleti E. Antibiotic tolerance in strains of Staphylococcus aureus. J Antimicrob Chemother. 1981 Jun;7(6):599–605. doi: 10.1093/jac/7.6.599. [DOI] [PubMed] [Google Scholar]
  70. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pelletier L. L., Jr, Baker C. B. Oxacillin, cephalothin, and vancomycin tube macrodilution MBC result reproducibility and equivalence to MIC results for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates. Antimicrob Agents Chemother. 1988 Mar;32(3):374–377. doi: 10.1128/aac.32.3.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Pelletier L. L., Jr Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Dec;26(6):815–818. doi: 10.1128/aac.26.6.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Peterson L. R., Denny A. E., Gerding D. N., Hall W. H. Determination of tolerance to antibiotic bactericidal activity on Kirby-Bauer susceptibility plates. Am J Clin Pathol. 1980 Nov;74(5):645–650. doi: 10.1093/ajcp/74.5.645. [DOI] [PubMed] [Google Scholar]
  74. Peterson L. R., Gerding D. N., Hall W. H., Schierl E. A. Medium-dependent variation in bactericidal activity of antibiotics against susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 1978 Apr;13(4):665–668. doi: 10.1128/aac.13.4.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Peterson L. R., Gerding D. N. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev Infect Dis. 1980 May-Jun;2(3):340–348. doi: 10.1093/clinids/2.3.340. [DOI] [PubMed] [Google Scholar]
  76. Peterson L. R., Gerding D. N., Moody J. A., Fasching C. E. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrob Agents Chemother. 1984 May;25(5):545–552. doi: 10.1128/aac.25.5.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Peterson L. R., Moody J. A., Fasching C. E., Gerding D. N. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model. Diagn Microbiol Infect Dis. 1987 Jun;7(2):127–136. doi: 10.1016/0732-8893(87)90030-7. [DOI] [PubMed] [Google Scholar]
  78. Pien F. D., Vosti K. L. Variation in performance of the serum bactericidal test. Antimicrob Agents Chemother. 1974 Sep;6(3):330–333. doi: 10.1128/aac.6.3.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Rahal J. J., Jr, Simberkoff M. S. Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens. Antimicrob Agents Chemother. 1979 Jul;16(1):13–18. doi: 10.1128/aac.16.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Rajashekaraiah K. R., Rice T., Rao V. S., Marsh D., Ramakrishna B., Kallick C. A. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med. 1980 Dec;93(6):796–801. doi: 10.7326/0003-4819-93-6-796. [DOI] [PubMed] [Google Scholar]
  81. Rammelkamp C. H., Keefer C. S. PENICILLIN: ITS ANTIBACTERIAL EFFECT IN WHOLE BLOOD AND SERUM FOR THE HEMOLYTIC STREPTOCOCCUS AND STAPHYLOCOCCUS AUREUS. J Clin Invest. 1943 Sep;22(5):649–657. doi: 10.1172/JCI101437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Reimer L. G., Stratton C. W., Reller L. B. Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother. 1981 Jun;19(6):1050–1055. doi: 10.1128/aac.19.6.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Robinson A., Bartlett R. C., Mazens M. F. Antimicrobial synergy testing based on antibiotic levels, minimal bactericidal concentration, and serum bactericidal activity. Am J Clin Pathol. 1985 Sep;84(3):328–333. doi: 10.1093/ajcp/84.3.328. [DOI] [PubMed] [Google Scholar]
  84. Rosenblatt J. E. Laboratory tests used to guide antimicrobial therapy. Mayo Clin Proc. 1987 Sep;62(9):799–805. doi: 10.1016/s0025-6196(12)62334-9. [DOI] [PubMed] [Google Scholar]
  85. Russell A. D. Minimum bactericidal concentrations. J Antimicrob Chemother. 1978 Jan;4(1):91–92. doi: 10.1093/jac/4.1.91-a. [DOI] [PubMed] [Google Scholar]
  86. Sabath L. D., Wheeler N., Laverdiere M., Blazevic D., Wilkinson B. J. A new type of penicillin resistance of Staphylococcus aureus. Lancet. 1977 Feb 26;1(8009):443–447. doi: 10.1016/s0140-6736(77)91941-9. [DOI] [PubMed] [Google Scholar]
  87. Sanders C. C. ARTs versus ASTs: where are we going? J Antimicrob Chemother. 1991 Nov;28(5):621–623. doi: 10.1093/jac/28.5.621. [DOI] [PubMed] [Google Scholar]
  88. Sanders C. C., Sanders W. E., Jr Effects of procedural variations on the activity of aminoglycosides in vitro. Am J Clin Pathol. 1975 Mar;63(3):438–445. doi: 10.1093/ajcp/63.3.438. [DOI] [PubMed] [Google Scholar]
  89. Sculier J. P., Klastersky J. Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med. 1984 Mar;76(3):429–435. doi: 10.1016/0002-9343(84)90662-4. [DOI] [PubMed] [Google Scholar]
  90. Shanholtzer C. J., Peterson L. R., Mohn M. L., Moody J. A., Gerding D. N. MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques. Antimicrob Agents Chemother. 1984 Aug;26(2):214–219. doi: 10.1128/aac.26.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Sherris J. C. Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother. 1986 Nov;30(5):633–637. doi: 10.1128/aac.30.5.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Stratton C. W. Serum bactericidal test. Clin Microbiol Rev. 1988 Jan;1(1):19–26. doi: 10.1128/cmr.1.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Taylor P. C., Schoenknecht F. D., Sherris J. C., Linner E. C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother. 1983 Jan;23(1):142–150. doi: 10.1128/aac.23.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Traub W. H., Sherris J. C. Studies on the interaction between serum bactericidal activity and antibiotics in vitro. Chemotherapy. 1970;15(2):70–83. doi: 10.1159/000220669. [DOI] [PubMed] [Google Scholar]
  95. Tubbs R. R. Insuring effective antimicrobial therapy: laboratory evaluation. J Am Osteopath Assoc. 1977 Apr;76(8):617–624. [PubMed] [Google Scholar]
  96. Tuomanen E., Durack D. T., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother. 1986 Oct;30(4):521–527. doi: 10.1128/aac.30.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Van der Auwera P., Aoun M., Meunier F. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts. Antimicrob Agents Chemother. 1991 Mar;35(3):451–457. doi: 10.1128/aac.35.3.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Venglarcik J. S., 3rd, Blair L. L., Dunkle L. M. pH-dependent oxacillin tolerance of Staphylococcus aureus. Antimicrob Agents Chemother. 1983 Feb;23(2):232–235. doi: 10.1128/aac.23.2.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Voorn G. P., Thompson J., Goessens W. H., Schmal-Bauer W., Broeders P. H., Michel M. F. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis. J Infect Dis. 1991 Mar;163(3):640–643. doi: 10.1093/infdis/163.3.640. [DOI] [PubMed] [Google Scholar]
  100. Weinstein M. P., Stratton C. W., Ackley A., Hawley H. B., Robinson P. A., Fisher B. D., Alcid D. V., Stephens D. S., Reller L. B. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med. 1985 Feb;78(2):262–269. doi: 10.1016/0002-9343(85)90436-x. [DOI] [PubMed] [Google Scholar]
  101. Widmer A. F., Frei R., Rajacic Z., Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990 Jul;162(1):96–102. doi: 10.1093/infdis/162.1.96. [DOI] [PubMed] [Google Scholar]
  102. Wilson E., Henry D. A., Smith J. A. Disk elution method for MICs and MBCs. Antimicrob Agents Chemother. 1990 Nov;34(11):2128–2132. doi: 10.1128/aac.34.11.2128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Wolfrey B. F., Lally R. T. Macrodilution MBC result reproducibility for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates. Antimicrob Agents Chemother. 1988 Sep;32(9):1464–1464. doi: 10.1128/aac.32.9.1464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Wolfson J. S., Swartz M. N. Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med. 1985 Apr 11;312(15):968–975. doi: 10.1056/NEJM198504113121507. [DOI] [PubMed] [Google Scholar]
  105. Woolfrey B. F., Lally R. T., Ederer M. N., Gresser-Burns M. Oxacillin killing curve patterns of Staphylococcus aureus isolates by agar dilution plate count method. Antimicrob Agents Chemother. 1987 Jan;31(1):16–20. doi: 10.1128/aac.31.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Woolfrey B. F., Lally R. T., Tait K. R. Influence of technical factor variations on serum inhibition and bactericidal titers. J Clin Microbiol. 1986 Jun;23(6):997–1000. doi: 10.1128/jcm.23.6.997-1000.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Zak O., Tosch W., Sande M. A. Correlation of antibacterial activities of antibiotics in vitro and in animal models of infection. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):273–282. doi: 10.1093/jac/15.suppl_a.273. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES